Camran Neshat is listed as a director on 1 SEC Form D filing by 1 issuer in Feb 2011: Avantis Medical Systems Inc (San Jose, CA — other health care — 2011; $17.9M reported sold to 40 investors).
What this means One deal on file with the SEC, filed Feb 2011. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Howard Palefsky (1 shared filing), John Reed (1 shared filing), Matthew Jenusaitis (1 shared filing) and Thomas J. Fogarty (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Camran. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Camran Neshat and found 2 differences: Offering amount changed between filings; No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.